Biophytis (BPTS) Stock Forecast, Price Target & Predictions
BPTS Stock Forecast
Biophytis stock forecast is as follows: an average price target of $15.00 (represents a 96.85% upside from BPTS’s last price of $7.62) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
BPTS Price Target
The average price target for Biophytis (BPTS) is $15.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $15.00. This represents a potential 96.85% upside from BPTS's last price of $7.62.
BPTS Analyst Ratings
According to 1 Wall Street analysts, Biophytis's rating consensus is 'Buy'. The analyst rating breakdown for BPTS stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Biophytis Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 21, 2024 | Joseph Pantginis | H.C. Wainwright | $15.00 | $8.22 | 82.48% | 96.85% |
The latest Biophytis stock forecast, released on Jun 21, 2024 by Joseph Pantginis from H.C. Wainwright, set a price target of $15.00, which represents a 82.48% increase from the stock price at the time of the forecast ($8.22), and a 96.85% increase from BPTS last price ($7.62).
Biophytis Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $15.00 | $15.00 |
| Last Closing Price | $7.62 | $7.62 | $7.62 |
| Upside/Downside | -100.00% | 96.85% | 96.85% |
In the current month, the average price target of Biophytis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Biophytis's last price of $7.62. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 21, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Biophytis's last stock rating was published by H.C. Wainwright on Jun 21, 2024. The company gave BPTS a "Buy" rating, the same as its previous rate.
Biophytis Financial Forecast
Biophytis Revenue Forecast
| Dec 23 | Sep 23 | |
|---|---|---|
| Revenue | - | - |
| Avg Forecast | - | - |
| High Forecast | - | - |
| Low Forecast | - | - |
| # Analysts | - | - |
| Surprise % | - | - |
Biophytis's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. BPTS's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Biophytis EBITDA Forecast
| Dec 23 | Sep 23 | |
|---|---|---|
| # Analysts | - | - |
| EBITDA | - | - |
| Avg Forecast | - | - |
| High Forecast | - | - |
| Low Forecast | - | - |
| Surprise % | - | - |
undefined analysts predict BPTS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Biophytis's previous annual EBITDA (undefined) of $NaN.
Biophytis Net Income Forecast
| Dec 23 | Sep 23 | |
|---|---|---|
| # Analysts | - | - |
| Net Income | - | - |
| Avg Forecast | $-709.12K | - |
| High Forecast | $-709.12K | - |
| Low Forecast | $-709.12K | - |
| Surprise % | - | - |
Biophytis's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. BPTS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Biophytis SG&A Forecast
| Dec 23 | Sep 23 | |
|---|---|---|
| # Analysts | - | - |
| SG&A | - | - |
| Avg Forecast | - | - |
| High Forecast | - | - |
| Low Forecast | - | - |
| Surprise % | - | - |
Biophytis's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to BPTS last annual SG&A of $NaN (undefined).
Biophytis EPS Forecast
| Dec 23 | Sep 23 | |
|---|---|---|
| # Analysts | - | - |
| EPS | - | - |
| Avg Forecast | $-0.27 | - |
| High Forecast | $-0.27 | - |
| Low Forecast | $-0.27 | - |
| Surprise % | - | - |
According to undefined Wall Street analysts, Biophytis's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to BPTS previous annual EPS of $NaN (undefined).
Biophytis Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AKTX | Akari Therapeutics | $3.32 | $12.00K | 361345.78% | - |
| SPRO | Spero Therapeutics | $1.32 | $10.00 | 657.58% | Buy |
| CHRS | Coherus BioSciences | $1.24 | $9.00 | 625.81% | Hold |
| PCSA | Processa Pharmaceuticals | $1.28 | $9.00 | 603.13% | Buy |
| IPHA | Innate Pharma | $2.31 | $10.00 | 332.90% | Buy |
| ANEB | Anebulo Pharmaceuticals | $1.80 | $6.00 | 233.33% | Buy |
| RZLT | Rezolute | $4.35 | $12.50 | 187.36% | Buy |
| BPTS | Biophytis | $8.22 | $15.00 | 82.48% | Buy |
| ELYM | Eliem Therapeutics | $7.39 | $13.00 | 75.91% | Buy |
| BOLT | Bolt Biotherapeutics | $0.65 | $1.00 | 53.85% | Hold |
| NRXP | NRx Pharmaceuticals | $1.63 | $2.00 | 22.70% | Buy |
| CYT | Cyteir Therapeutics | $3.02 | $2.00 | -33.77% | Sell |
| GRCL | Gracell Bio | $10.25 | $6.00 | -41.46% | Buy |
BPTS Forecast FAQ
Is Biophytis a good buy?
Yes, according to 1 Wall Street analysts, Biophytis (BPTS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of BPTS's total ratings.
What is BPTS's price target?
Biophytis (BPTS) average price target is $15 with a range of $15 to $15, implying a 96.85% from its last price of $7.62. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Biophytis stock go up soon?
According to Wall Street analysts' prediction for BPTS stock, the company can go up by 96.85% (from the last price of $7.62 to the average price target of $15), up by 96.85% based on the highest stock price target, and up by 96.85% based on the lowest stock price target.
Can Biophytis stock reach $11?
BPTS's average twelve months analyst stock price target of $15 supports the claim that Biophytis can reach $11 in the near future.
What are Biophytis's analysts' financial forecasts?
BPTS's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-709K (high $-709K, low $-709K), average SG&A $0 (high $0, low $0), and average EPS is $-0.273 (high $-0.273, low $-0.273).